# Non-Disclosure Agreement (NDA)

**MUTUAL NON-DISCLOSURE AGREEMENT**

**FOR GRID-BASED DCA TRADING TOOL COLLABORATION**

---

## ⚠️ IMPORTANT LEGAL NOTICE

**This is a template only and should be reviewed by a qualified attorney before use.**

This template provides a basic framework for protecting confidential information shared during collaboration on the Grid-Based DCA Trading Tool project. It should be customized for each specific collaboration and reviewed by legal counsel to ensure it meets your needs and complies with applicable laws.

---

## Agreement Details

**This Agreement is entered into on**: `[DATE]`

**Between**:

**Disclosing Party (Owner)**:
- Name: Kevin Weng
- Address: `[ADDRESS]`
- Email: kevin.weng.ai@gmail.com

**Receiving Party (Collaborator)**:
- Name: `[COLLABORATOR NAME]`
- Address: `[COLLABORATOR ADDRESS]`
- Email: `[COLLABORATOR EMAIL]`

**Collectively referred to as**: "the Parties"

---

## Recitals

WHEREAS, the Disclosing Party has developed proprietary algorithms, methodologies, and software for grid-based dollar cost averaging (DCA) trading strategies;

WHEREAS, the Receiving Party desires to collaborate on, contribute to, or learn about the Grid-Based DCA Trading Tool project;

WHEREAS, in connection with such collaboration, the Disclosing Party may disclose certain confidential and proprietary information to the Receiving Party;

WHEREAS, the Parties wish to protect the confidentiality of such information;

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, the Parties agree as follows:

---

## 1. Definition of Confidential Information

### 1.1 Confidential Information Includes

For purposes of this Agreement, "Confidential Information" means any and all information, whether written, oral, electronic, visual, or in any other form, disclosed by the Disclosing Party to the Receiving Party, including but not limited to:

**Trade Secrets**:
- Source code and algorithms in the following files:
  - `/backend/services/dcaBacktestService.js`
  - `/backend/services/portfolioBacktestService.js`
  - `/backend/services/batchBacktestService.js`
  - `/backend/utils/calculateBeta.js`
  - `/backend/utils/performanceMetrics.js`
- Implementation details and techniques
- Proprietary formulas and calculations
- Performance optimization methods

**Business Information**:
- Strategic plans and roadmaps
- Customer data and usage statistics
- Financial information
- Marketing strategies
- Partner relationships

**Innovations**:
- Grid-based DCA methodology
- DCA Suitability Score algorithm
- Beta Grouping Analysis techniques
- Consecutive Incremental Profit tracking
- Dynamic Grid Spacing algorithms
- Other innovations documented in ORIGINALITY-ASSESSMENT.md

**Technical Information**:
- System architecture and design
- Database schemas
- API specifications
- Testing methodologies
- Debugging techniques

### 1.2 Confidential Information Excludes

Confidential Information does not include information that:

a) **Public Domain**: Is or becomes publicly available through no breach of this Agreement by the Receiving Party;

b) **Prior Knowledge**: Was known to the Receiving Party prior to disclosure by the Disclosing Party, as evidenced by written records;

c) **Independent Development**: Is independently developed by the Receiving Party without use of or reference to the Confidential Information, as evidenced by written records;

d) **Third-Party Disclosure**: Is rightfully received by the Receiving Party from a third party without restriction and without breach of this Agreement;

e) **Required Disclosure**: Is required to be disclosed by law, court order, or governmental authority (provided that the Receiving Party gives the Disclosing Party prompt written notice of such requirement to allow the Disclosing Party to seek protective measures).

---

## 2. Obligations of Receiving Party

### 2.1 Non-Disclosure

The Receiving Party agrees to:

a) Hold all Confidential Information in strict confidence;

b) Not disclose Confidential Information to any third party without the prior written consent of the Disclosing Party;

c) Use the Confidential Information solely for the purpose of collaboration on the Grid-Based DCA Trading Tool project ("Permitted Purpose");

d) Not use the Confidential Information for any other purpose, including personal projects, competing products, or commercial ventures outside the scope of the collaboration.

### 2.2 Standard of Care

The Receiving Party shall:

a) Protect the Confidential Information using the same degree of care it uses to protect its own confidential information, but in no event less than reasonable care;

b) Take all reasonable precautions to prevent unauthorized disclosure, including:
   - Storing files on encrypted devices
   - Using strong passwords and 2FA
   - Limiting access to authorized personnel only
   - Marking confidential materials appropriately

### 2.3 Limited Disclosure

The Receiving Party may disclose Confidential Information only to:

a) Its employees, contractors, or agents who:
   - Have a legitimate need to know for the Permitted Purpose;
   - Have been informed of the confidential nature of the information;
   - Have agreed in writing to be bound by confidentiality obligations at least as restrictive as those in this Agreement.

b) The Receiving Party remains responsible for any breach of this Agreement by its employees, contractors, or agents.

### 2.4 No Reverse Engineering

The Receiving Party agrees not to:

a) Reverse engineer, decompile, or disassemble any software or algorithms disclosed;

b) Attempt to derive trade secrets from the Confidential Information;

c) Use the Confidential Information to develop competing products or services.

---

## 3. Ownership and Rights

### 3.1 Ownership

All Confidential Information remains the sole property of the Disclosing Party. No license or other rights are granted under this Agreement except as expressly stated.

### 3.2 Copyright

The Receiving Party acknowledges that:

a) The Grid-Based DCA Trading Tool is protected by copyright (© 2025 Kevin Weng. All Rights Reserved.);

b) The source code is licensed under the MIT License, but this does not grant rights to disclose trade secret implementations;

c) The innovations are documented as defensive publication in ORIGINALITY-ASSESSMENT.md.

### 3.3 No Transfer of Rights

This Agreement does not grant the Receiving Party any rights to:

a) Patents, copyrights, trademarks, or other intellectual property;

b) Commercialize or license the Confidential Information;

c) Claim ownership or inventorship of the innovations.

---

## 4. Term and Termination

### 4.1 Term

This Agreement shall commence on the date first written above and shall continue for:

**Duration**: `[SPECIFY DURATION, e.g., "two (2) years from the date of first disclosure" or "until terminated by either Party"]`

### 4.2 Termination

Either Party may terminate this Agreement:

a) By providing thirty (30) days written notice to the other Party;

b) Immediately upon material breach by the other Party.

### 4.3 Survival of Obligations

Upon termination, the Receiving Party shall:

a) **Immediately cease** all use of Confidential Information;

b) **Return or destroy** all materials containing Confidential Information within ten (10) days;

c) **Certify in writing** that all copies have been returned or destroyed;

d) **Continue to maintain confidentiality** for a period of:
   - **Trade Secrets**: Indefinitely (as long as they remain trade secrets)
   - **Other Confidential Information**: Five (5) years from termination

---

## 5. Remedies

### 5.1 Irreparable Harm

The Receiving Party acknowledges that:

a) Breach of this Agreement will cause irreparable harm to the Disclosing Party;

b) Monetary damages may be inadequate to compensate for such breach;

c) The Disclosing Party shall be entitled to seek equitable relief, including injunctions and specific performance, without posting bond.

### 5.2 Damages

In addition to equitable relief, the Disclosing Party may seek:

a) Actual damages for economic harm;

b) Unjust enrichment disgorgement;

c) Exemplary damages (up to 2x actual damages for willful violations);

d) Attorney's fees and court costs.

### 5.3 No Limitation

These remedies are cumulative and not exclusive of any other remedies available at law or in equity.

---

## 6. General Provisions

### 6.1 Governing Law

This Agreement shall be governed by and construed in accordance with the laws of:

**Jurisdiction**: `[SPECIFY STATE/COUNTRY, e.g., "the State of California, USA"]`

Without regard to its conflict of laws provisions.

### 6.2 Dispute Resolution

Any disputes arising under this Agreement shall be resolved by:

**Method**: `[SPECIFY: "binding arbitration" or "litigation in the courts of [jurisdiction]"]`

### 6.3 Entire Agreement

This Agreement constitutes the entire agreement between the Parties regarding the subject matter hereof and supersedes all prior or contemporaneous agreements, whether written or oral.

### 6.4 Amendment

This Agreement may be amended only by a written instrument signed by both Parties.

### 6.5 Severability

If any provision of this Agreement is held to be invalid or unenforceable, the remaining provisions shall remain in full force and effect.

### 6.6 Waiver

No waiver of any breach of this Agreement shall be deemed a waiver of any subsequent breach.

### 6.7 Assignment

Neither Party may assign this Agreement without the prior written consent of the other Party, except that the Disclosing Party may assign this Agreement in connection with a merger, acquisition, or sale of substantially all its assets.

### 6.8 Notices

All notices under this Agreement shall be in writing and sent to:

**Disclosing Party**:
- Email: kevin.weng.ai@gmail.com
- Address: `[ADDRESS]`

**Receiving Party**:
- Email: `[COLLABORATOR EMAIL]`
- Address: `[COLLABORATOR ADDRESS]`

### 6.9 Counterparts

This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument.

---

## 7. Special Provisions for Open Source Collaboration

### 7.1 MIT License Coexistence

The Parties acknowledge that:

a) The Grid-Based DCA Trading Tool source code is licensed under the MIT License;

b) This NDA protects **trade secret implementations** and **confidential business information**, not the right to use the MIT-licensed code;

c) The Receiving Party may use, modify, and distribute the code under the MIT License, but may not disclose trade secret implementations or confidential information covered by this Agreement.

### 7.2 Public Contributions

If the Receiving Party contributes code to the public repository:

a) Contributions are subject to the MIT License;

b) The Receiving Party may not include confidential information or trade secrets in public contributions;

c) The Receiving Party must ensure contributions do not disclose proprietary algorithms or techniques.

### 7.3 Defensive Publication

The Parties acknowledge that:

a) Innovations are documented in ORIGINALITY-ASSESSMENT.md as defensive publication;

b) This establishes prior art but does not authorize public disclosure of implementation details;

c) The Receiving Party may reference the defensive publication but may not disclose trade secret implementations.

---

## 8. Acknowledgment and Acceptance

By signing below, the Receiving Party acknowledges that they have:

- Read and understood this Agreement
- Had the opportunity to seek legal counsel
- Agreed to be bound by all terms and conditions
- Understood the consequences of breach

---

## Signatures

**DISCLOSING PARTY (Owner)**:

Signature: `_______________________________`

Name: Kevin Weng

Date: `_______________________________`

---

**RECEIVING PARTY (Collaborator)**:

Signature: `_______________________________`

Name: `[COLLABORATOR NAME]`

Date: `_______________________________`

---

## Appendix A: List of Protected Files

The following files contain trade secret information covered by this Agreement:

1. `/backend/services/dcaBacktestService.js` - Core DCA algorithm
2. `/backend/services/portfolioBacktestService.js` - Portfolio optimization
3. `/backend/services/batchBacktestService.js` - Batch processing
4. `/backend/utils/calculateBeta.js` - Beta calculation
5. `/backend/utils/performanceMetrics.js` - Metrics algorithms

**Note**: This list may be updated. The Receiving Party will be notified of any additions.

---

## Appendix B: Permitted Use Examples

**Examples of Permitted Use**:
- ✅ Reviewing code to contribute bug fixes
- ✅ Testing features for quality assurance
- ✅ Collaborating on approved project enhancements
- ✅ Learning for the purpose of contributing to the project

**Examples of Prohibited Use**:
- ❌ Using algorithms in personal trading projects
- ❌ Sharing code with unauthorized parties
- ❌ Posting implementation details on forums or blogs
- ❌ Developing competing products using the algorithms
- ❌ Disclosing formulas or techniques to third parties

---

## Appendix C: Customization Checklist

Before using this NDA, customize the following:

- [ ] `[DATE]` - Agreement effective date
- [ ] `[COLLABORATOR NAME]` - Receiving Party's name
- [ ] `[COLLABORATOR ADDRESS]` - Receiving Party's address
- [ ] `[COLLABORATOR EMAIL]` - Receiving Party's email
- [ ] `[ADDRESS]` - Disclosing Party's address (if applicable)
- [ ] `[SPECIFY DURATION]` - Agreement duration
- [ ] `[SPECIFY STATE/COUNTRY]` - Governing law jurisdiction
- [ ] `[SPECIFY: "binding arbitration" or "litigation"]` - Dispute resolution method
- [ ] Review entire agreement for applicability to specific collaboration
- [ ] Have both parties initial each page (if desired)
- [ ] Consult legal counsel before execution

---

**Template Version**: 1.0
**Last Updated**: January 2025
**Copyright © 2025 Kevin Weng. All Rights Reserved.**

**DISCLAIMER**: This template is provided for informational purposes only and does not constitute legal advice. Consult with a qualified attorney before using this template.
